Short Interest in Natus Medical Inc (BABY) Rises By 56.1%

Natus Medical Inc (NASDAQ:BABY) was the recipient of a significant growth in short interest in October. As of October 31st, there was short interest totalling 2,466,968 shares, a growth of 56.1% from the October 15th total of 1,580,878 shares. Based on an average trading volume of 358,103 shares, the short-interest ratio is currently 6.9 days. Approximately 7.7% of the company’s stock are short sold.

In related news, insider Jonathan Kennedy sold 47,600 shares of the company’s stock in a transaction on Thursday, August 30th. The shares were sold at an average price of $36.85, for a total value of $1,754,060.00. Following the sale, the insider now directly owns 161,628 shares of the company’s stock, valued at $5,955,991.80. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Corporate insiders own 5.50% of the company’s stock.

Several large investors have recently modified their holdings of BABY. Eagle Asset Management Inc. raised its holdings in shares of Natus Medical by 246.5% during the second quarter. Eagle Asset Management Inc. now owns 1,801,275 shares of the medical equipment provider’s stock worth $62,143,000 after purchasing an additional 1,281,395 shares during the period. Carillon Tower Advisers Inc. acquired a new stake in shares of Natus Medical during the second quarter worth $41,626,000. BlackRock Inc. raised its holdings in shares of Natus Medical by 10.8% during the second quarter. BlackRock Inc. now owns 4,793,172 shares of the medical equipment provider’s stock worth $165,363,000 after purchasing an additional 466,409 shares during the period. Janus Henderson Group PLC raised its holdings in shares of Natus Medical by 14.6% during the third quarter. Janus Henderson Group PLC now owns 3,111,761 shares of the medical equipment provider’s stock worth $110,934,000 after purchasing an additional 396,772 shares during the period. Finally, Rutabaga Capital Management LLC MA acquired a new stake in shares of Natus Medical during the third quarter worth $9,272,000. 95.86% of the stock is currently owned by institutional investors.

Several analysts recently issued reports on the stock. Zacks Investment Research cut shares of Natus Medical from a “hold” rating to a “strong sell” rating in a report on Friday, October 26th. BidaskClub cut shares of Natus Medical from a “buy” rating to a “hold” rating in a report on Friday, July 13th. ValuEngine cut shares of Natus Medical from a “hold” rating to a “sell” rating in a report on Saturday. Finally, Roth Capital set a $36.00 target price on shares of Natus Medical and gave the stock a “buy” rating in a report on Thursday, October 25th. Two analysts have rated the stock with a sell rating, two have assigned a hold rating and two have issued a buy rating to the company. The company has a consensus rating of “Hold” and an average target price of $42.50.

Shares of NASDAQ:BABY opened at $29.95 on Friday. The firm has a market cap of $1.05 billion, a price-to-earnings ratio of 20.66 and a beta of 0.54. Natus Medical has a 1-year low of $27.69 and a 1-year high of $42.80. The company has a debt-to-equity ratio of 0.28, a quick ratio of 2.31 and a current ratio of 3.21.

Natus Medical (NASDAQ:BABY) last issued its earnings results on Wednesday, October 24th. The medical equipment provider reported $0.40 earnings per share for the quarter, missing the Zacks’ consensus estimate of $0.42 by ($0.02). The business had revenue of $130.60 million for the quarter, compared to analyst estimates of $132.92 million. Natus Medical had a positive return on equity of 11.34% and a negative net margin of 3.53%. The firm’s revenue for the quarter was up 6.5% on a year-over-year basis. During the same period last year, the company posted $0.40 earnings per share. As a group, equities research analysts anticipate that Natus Medical will post 1.48 EPS for the current year.

TRADEMARK VIOLATION NOTICE: “Short Interest in Natus Medical Inc (BABY) Rises By 56.1%” was reported by Sports Perspectives and is the sole property of of Sports Perspectives. If you are accessing this piece on another publication, it was illegally copied and reposted in violation of US & international trademark and copyright legislation. The legal version of this piece can be read at https://sportsperspectives.com/2018/11/10/short-interest-in-natus-medical-inc-baby-rises-by-56-1.html.

About Natus Medical

Natus Medical Incorporated provides newborn care, neurology, and hearing and balance assessment healthcare products and services worldwide. It offers products and services used for the screening, diagnosis, detection, treatment, monitoring, and tracking of common medical ailments in newborn care, hearing impairment, neurological dysfunction, epilepsy, sleep disorders, neuromuscular diseases, and balance and mobility disorders.

Featured Story: Terms to Better Understand Call Options

Receive News & Ratings for Natus Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Natus Medical and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply